Association of complement factor H Y402H polymorphism with phenotype of neovascular age related macular degeneration in Israel
Authors:
- Itay ChowersICItay Chowers
- Yoram CohenYCYoram Cohen
- Nitza Goldenberg-CohenNGNitza Goldenberg-Cohen
- Joaquin Vicuna-KojchenJVJoaquin Vicuna-Kojchen
- Alejandro LichtingerALAlejandro Lichtinger
- Orly WeinsteinOWOrly Weinstein
- Ayala PollackAPAyala Pollack
- Ruth Axer-SiegelRARuth Axer-Siegel
- Itzhak HemoIHItzhak Hemo
- Edward AverbukhEAEdward Averbukh
- Eyal BaninEBEyal Banin
- Tal MeirTMTal Meir
Open Access
- 8 October 2008
- journal article
- Vol. 14, 1829-1834
Abstract
The Tyr402His variant of complement factor H (CFH) is associated with age-related macular degeneration (AMD) in several populations. Our aim was to evaluate if this single nucleotide polymorphism (SNP) is associated with AMD in the Israeli population and see if it underlies heterogeneity in clinical manifestation and responses to photodynamic therapy (PDT), which characterize neovascular AMD (NVAMD). Genotyping for the Tyr402His variant was performed in 240 NVAMD patients (78.1±7 age range) and 118 controls (70.8±8.2 age range). Genotyping was correlated with clinical characteristics and treatment parameters in sequential 131 NVAMD patients who underwent PDT. TheTyr402His coding allele was associated with NVAMD in the Israeli population: odds ratio (OR)=1.9; 95% confidence interval (CI)=1.3–2.6; p=0.0002. Homozygosity for this variant was associated with an OR of 3.4 (95% CI: 1.7–6.8) for having AMD. There was no association among this SNP and age of onset of NVAMD, gender, neovascular lesion size, initial or final visual acuity, and number of PDT sessions required. In accordance with findings from the majority of previous study populations, the Tyr402His variant of CFH is associated with NVAMD in Israel. However, heterogeneity in clinical manifestations of NVAMD and in its response to PDT is not underlined by this CFH variant and may be accounted for by other genetic and environmental factors.Keywords
This publication has 40 references indexed in Scilit:
- HTRA1 Promoter Polymorphism in Wet Age-Related Macular DegenerationScience, 2006
- Analysis ofCFH,TLR4, andAPOEPolymorphism in India Suggests the Tyr402His Variant ofCFHto be a Global Marker for Age-Related Macular DegenerationInvestigative Ophthalmology & Visual Science, 2006
- Polymorphism p.402Y>H in the complement factor H protein is a risk factor for age related macular degeneration in an Italian populationBritish Journal of Ophthalmology, 2006
- The Genetics of Age-Related Macular Degeneration: A Review of Progress to DateSurvey of Ophthalmology, 2006
- Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease riskHuman Molecular Genetics, 2005
- Strong Association of the Y402H Variant in Complement Factor H at 1q32 with Susceptibility to Age-Related Macular DegenerationThe American Journal of Human Genetics, 2005
- A common haplotype in the complement regulatory gene factor H ( HF1/CFH ) predisposes individuals to age-related macular degenerationProceedings of the National Academy of Sciences, 2005
- Complement Factor H Polymorphism in Age-Related Macular DegenerationScience, 2005
- Complement Factor H Variant Increases the Risk of Age-Related Macular DegenerationScience, 2005
- Complement Factor H Polymorphism and Age-Related Macular DegenerationScience, 2005